Prophylaxis against colorectal cancer.
Colorectal cancer is diagnosed in more than 3000 people every year in Denmark, with a population of 5 million, and 2000 die from this disease every year. The aetiology of the disease is complex, but an increasing number of cancers have been related to genetics and Denmark is contributing with a well-established register of familial adenomatous polyposis and a recently founded register for hereditary nonpolyposis colorectal cancer, both with major international relationships. The Danish tradition of epidemiology and clinical trials has also been demonstrated in population screening trials for colorectal cancer in average-risk persons as well as high-risk groups with precursors of the disease. The present review places Danish contributions within the prophylaxis of colorectal cancer during the last decade in an international context.
Bülow
S
S
Dept. of Surgical Gastroenterology, Hvidovre University Hospital, Denmark.
Kronborg
O
O
D011125:Adenomatous Polyposis Coli / Q000453:epidemiology / Q000517:prevention & control*; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000453:epidemiology / Q000517:prevention & control*; D003718:Denmark / Q000453:epidemiology; D006801:Humans; D008403:Mass Screening; D016609:Neoplasms, Second Primary / Q000453:epidemiology; D012042:Registries; D012307:Risk Factors